LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
61.33
-1.05 (-1.68%)
At close: Jan 13, 2026, 4:00 PM EST
61.35
+0.02 (0.03%)
Pre-market: Jan 14, 2026, 4:25 AM EST
LivaNova Market Cap
LivaNova has a market cap or net worth of $3.35 billion as of January 14, 2026. Its market cap has increased by 31.92% in one year.
Market Cap
3.35B
Enterprise Value
3.19B
1-Year Change
31.92%
Ranking
Category
Stock Price
$61.33
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has decreased from $3.42B to $3.35B, a decrease of -1.94%. That is a compound annual growth rate of -0.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 3.41B | 1.38% |
| Dec 31, 2025 | 3.36B | 33.61% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
| Oct 19, 2015 | 3.42B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.28B |
| Johnson & Johnson | 499.21B |
| AbbVie | 388.21B |
| UnitedHealth Group | 305.76B |
| AstraZeneca | 295.57B |
| Merck & Co. | 273.20B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |